Published in TB and Outbreaks Week, March 22nd, 1999
Compared with the recent rapid advances in the diagnosis of tuberculosis, advances in the treatment of tuberculosis have occurred at a snail,s pace. Initial treatment regimens average six months, even with the addition of pyrazinamide in the first two months to an isoniazid, rifampicin, and streptomycin or ethambutol regimen.
In addition, it is not always easy to treat patients who cannot receive standard agents including isoniazid and rifampicin due to the adverse effects of these drugs or drug resistance.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week